Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-15
2009-06-23
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S263100, C514S392000, C514S400000, C514S449000, C514S649000, C514S653000
Reexamination Certificate
active
07550466
ABSTRACT:
The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using α-adrenergic antagonists and β-adrenergic agonists (particularly β2-adrenergic agonists) alone or in combination.
REFERENCES:
patent: 5070084 (1991-12-01), Campbell
patent: 5541188 (1996-07-01), Maltin
Lorton Dianne
Lubahn Cheri
Henley, III Raymond J
Jennings Strouss & Salmon
Mott Joseph W.
Sun Health Research Institute
LandOfFree
Alpha and/or β-adrenergic antagonists and agonists to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha and/or β-adrenergic antagonists and agonists to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha and/or β-adrenergic antagonists and agonists to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4056599